Mary Relling, PharmD (St. Jude Children’s Research Hospital) moderates this panel discussion on Issues for Clinical Implementation of Pharmacogenomic Testing at the 2016 PGRN-ASHG Symposium.
Panelists: Dan Roden, MD (Vanderbilt University/eMerge), David Litwack, PhD (U.S. Food and Drug Administration) and Scott Weiss, MD (Harvard Medical School)
JOIN the PGRN:
[ Ссылка ]
All individuals interested in pharmacogenomics research may apply.
